Candel Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $184k | 36k | 5.10 |
| 2025-03-31 | $309k | 55k | 5.65 |
| 2024-12-31 | $566k | 65k | 8.68 |
| 2024-09-30 | $210k | 30k | 6.93 |
| 2024-06-30 | $113k | 18k | 6.20 |
| 2022-06-30 | $33k | 10k | 3.29 |
| 2022-03-31 | $53k | 11k | 5.04 |
| 2021-12-31 | $83k | 11k | 7.84 |